triazoles has been researched along with 3-(1-(3-(biphenyl-4-ylamino)-3-oxopropyl)-1h-1,2,3-triazol-4-yl)-6-hydroxy-1-methyl-2-phenyl-1h-indole-5-carboxylic acid in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, RJ; Dong, Y; Gunawan, AM; He, Y; Jiang, ZX; Liu, S; Nabinger, SC; Wang, L; Wu, L; Yang, Z; Yu, Z; Zhang, X; Zhang, ZY | 1 |
| Boswell, HS; Bowling, JD; Chan, RJ; Feng, GS; Fukuda, S; Goenka, S; He, Y; Kapur, R; Li, XJ; Liu, Z; Nabinger, SC; Ramdas, B; Richine, B; Sandusky, GE; Yu, M; Zeng, L; Zhang, X; Zhang, ZY | 1 |
| Craig, AW; Everingham, S; Kapur, R; Sharma, N; Zeng, LF; Zhang, ZY | 1 |
| Adderley, T; Christopher, G; Irwin, MS; Kano, Y; Kee, L; Ladumor, Y; Ohh, M; Robinson, CM; Valencia-Sama, I | 1 |
4 other study(ies) available for triazoles and 3-(1-(3-(biphenyl-4-ylamino)-3-oxopropyl)-1h-1,2,3-triazol-4-yl)-6-hydroxy-1-methyl-2-phenyl-1h-indole-5-carboxylic acid
| Article | Year |
|---|---|
Salicylic acid based small molecule inhibitor for the oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2).
Topics: Animals; Apoptosis; Area Under Curve; Cell Line; Cell Line, Tumor; Cells, Cultured; Crystallography, X-Ray; Enzyme Inhibitors; Female; Humans; Indoles; Inhibitory Concentration 50; Mice; Mice, Inbred C57BL; Mice, Nude; Models, Chemical; Models, Molecular; Molecular Structure; Mutation; Neoplasms; Protein Binding; Protein Structure, Tertiary; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Salicylic Acid; Small Molecule Libraries; Triazoles; Xenograft Model Antitumor Assays | 2010 |
The protein tyrosine phosphatase, Shp2, positively contributes to FLT3-ITD-induced hematopoietic progenitor hyperproliferation and malignant disease in vivo.
Topics: Animals; Base Sequence; bcl-X Protein; Blotting, Western; Bone Marrow Transplantation; Cell Proliferation; Chromatin Immunoprecipitation; Fluorescent Antibody Technique; fms-Like Tyrosine Kinase 3; Hematopoietic Stem Cells; Humans; Immunoprecipitation; Indoles; Leukemia, Myeloid, Acute; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Sequence Data; Mutation; Phosphorylation; Precursor Cells, B-Lymphoid; Promoter Regions, Genetic; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; STAT5 Transcription Factor; Survival Rate; Tandem Repeat Sequences; Triazoles | 2013 |
Oncogenic KIT-induced aggressive systemic mastocytosis requires SHP2/PTPN11 phosphatase for disease progression in mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Proliferation; Dasatinib; Disease Progression; Drug Synergism; Humans; Indoles; Mastocytosis, Systemic; Mice; Mice, Transgenic; Protein Kinase Inhibitors; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Proto-Oncogene Proteins c-kit; Signal Transduction; Triazoles | 2014 |
Topics: Aminopyridines; Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Genes, ras; Heterografts; Humans; Indoles; Male; MAP Kinase Signaling System; Mice, Inbred NOD; Mice, SCID; Mitogen-Activated Protein Kinase Kinases; Mutation; Neoplasm Recurrence, Local; Neuroblastoma; Piperidines; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Pyridones; Pyrimidines; Pyrimidinones; Pyrroles; Triazoles; Vemurafenib | 2020 |